Top 5 Undervalued Stocks To Invest In Right Now

When it comes to stock ideas, quality is often better than quantity. In other words, doubling down on a good investment can make more sense than buying a new stock simply for the sake of diversification.

That is the case with this month’s dividend stock pick: Broadcom (NASDAQ:AVGO). Last month I named the semiconductor company one of two undervalued dividend stocks. But Broadcom’s attractiveness as a dividend stock, even after the stock’s 15% gain since my recommendation last month, is worth emphasizing.

Here are three reasons for income investors to bet on this dividend stock:

Image source: Getty Images.

1. Broadcom has a meaningful dividend yield

With its annual dividend payments per share equal to 3% of its stock price, Broadcom is one of a few high-quality megacap stocks with such a heady dividend yield. The average dividend yield of stocks in the S&P 500 is more than 1 percentage point lower, at 1.8%. 

Top 5 Undervalued Stocks To Invest In Right Now: GWG Holdings, Inc(GWGH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Here are some of the news articles that may have effected Accern Sentiment’s analysis:

    Get GWG alerts:

    Critical Review: Citizens (CIA) vs. GWG (GWGH) (americanbankingnews.com) (Watch) Zibanejad scores in Sweden’s win over Russia (sny.tv) GWG Holdings’ (GWGH) CEO Jon Sabes on Q1 2018 Results – Earnings Call Transcript (msn.com) Edited Transcript of GWGH earnings conference call or presentation 14-May-18 8:30pm GMT (finance.yahoo.com) DWWA judge profile: Davide Buongiorno (decanter.com)

    A number of equities research analysts recently commented on the company. Zacks Investment Research raised GWG from a “hold” rating to a “buy” rating and set a $9.25 price target for the company in a research report on Wednesday, April 11th. ValuEngine lowered GWG from a “hold” rating to a “sell” rating in a research report on Monday, May 14th. Finally, Maxim Group reaffirmed a “buy” rating and set a $14.00 target price on shares of GWG in a research report on Tuesday, January 23rd.

  • [By Logan Wallace]

    ValuEngine cut shares of GWG (NASDAQ:GWGH) from a sell rating to a strong sell rating in a report issued on Friday morning.

    Several other equities analysts have also issued reports on GWGH. Zacks Investment Research lowered GWG from a strong-buy rating to a hold rating in a research note on Tuesday, July 17th. Maxim Group reissued a buy rating and issued a $14.00 price target on shares of GWG in a research note on Thursday, August 16th.

Top 5 Undervalued Stocks To Invest In Right Now: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Just look at last week’s big winner, OncoCyte Corp. (NYSE: OCX). The stock surged nearly 160% in less than a week, and it still trades for just $4.98 a share.

  • [By Jon C. Ogg]

    OncoCyte Corp. (NYSE: OCX) was started as Overweight with a $6 price target (versus a $3.84 close) at Piper Jaffray. It has a 52-week range of $1.10 to $6.92 and a market cap of only $191 million.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 5 Undervalued Stocks To Invest In Right Now: Liberty Global plc(LBTYA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Epoch Investment Partners Inc. grew its position in shares of Liberty Global PLC Class A (NASDAQ:LBTYA) by 1.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,946,065 shares of the company’s stock after buying an additional 31,331 shares during the period. Epoch Investment Partners Inc. owned about 0.36% of Liberty Global PLC Class A worth $92,241,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Liberty Global PLC Class A (NASDAQ:LBTYA) was the target of some unusual options trading activity on Monday. Investors acquired 1,977 put options on the company. This is an increase of approximately 1,312% compared to the average daily volume of 140 put options.

  • [By Motley Fool Transcribers]

    Liberty Global PLC  (NASDAQ:LBTYA)Q4 2018 Earnings Conference CallFeb. 27, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern’s rankings:

    Get Liberty Global alerts:

    TalkTalk counts the cost of biggest ever customer gains (finance.yahoo.com) $0.12 Earnings Per Share Expected for Liberty Global (LBTYA) This Quarter (americanbankingnews.com) Deal Valuation Disappointing But Liberty Global’s (LBTYA) Valuation Is Too Cheap To Ignore – Citi (streetinsider.com) Virgin Media searches for new leader as chief executive prepares to log off (telegraph.co.uk) Vodafone ‘highly likely’ to receive approval for Liberty Global deal, says Citi (proactiveinvestors.co.uk)

    Shares of Liberty Global traded down $0.17, hitting $28.77, on Thursday, Marketbeat reports. 1,665,800 shares of the company traded hands, compared to its average volume of 2,234,886. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.33 and a current ratio of 0.33. Liberty Global has a 52 week low of $28.00 and a 52 week high of $39.73. The company has a market capitalization of $23.20 billion, a PE ratio of -12.56, a P/E/G ratio of 5.66 and a beta of 1.62.

  • [By Stephan Byrd]

    Liberty Global (NASDAQ: LBTYA) is one of 32 public companies in the “Cable & other pay television services” industry, but how does it contrast to its competitors? We will compare Liberty Global to related companies based on the strength of its institutional ownership, analyst recommendations, dividends, valuation, risk, profitability and earnings.

Top 5 Undervalued Stocks To Invest In Right Now: Medical Marijuana, Inc. (MJNA)

Advisors’ Opinion:

  • [By Sean Williams]

    If I were to choose two marijuana stocks right off the bat that I’d rather watch from the sidelines and never buy, it’d be medical cannabis company Medical Marijuana Inc. (NASDAQOTH:MJNA) and cannabinoid-based drug developer AXIM Biotechnologies (NASDAQOTH:AXIM). The reason they’re listed together is because Medical Marijuana Inc. owns 22.67 million shares of AXIM, which is about 40% of its outstanding share count. Their futures really are tied together.

  • [By Sean Williams]

    The only other marijuana stock to take a dive in September was small-cap Medical Marijuana, Inc. (NASDAQOTH:MJNA), which shed around 10% of its value.

  • [By ]

    Cronos was the first cannabis company to trade on NASDAQ, but the first American cannabis company to do it was Medical Marijuana Inc. (MJNA) . Developing legal cannabidiol (CBD) products made from hemp, Medical Marijuana Inc. had a major increase in sales from 2016 to 2017 and has begun looking into an expansion into international markets. Like with Aurora, these expenses have meant that it’s not making much of a profit. With encouraging signs and warning signs each abounding, it comes down to whether you think this could be worth the risk.

  • [By Sean Williams]

    One company aiming to capitalize on this trend in the U.S. is Medical Marijuana Inc. (NASDAQOTH:MJNA), the first publicly traded pot stock in the United States. Medical Marijuana’s RSHO-X brand focuses on cannabidiol-based hemp oils. Cannabidiol is the non-psychoactive component of the cannabis plant known for its perceived medical benefits. Considering that even older Americans have a positive view on medical cannabis, this is the type of company and product that could do well with boomers. Perhaps not surprisingly, Medical Marijuana Inc. recorded its strongest sales month in history in August. 

Top 5 Undervalued Stocks To Invest In Right Now: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Forward Pharma A/S (NASDAQ: FWP) shares gained 88.18 percent to close at $4.14 on Tuesday.
    Regional Health Properties, Inc. (NYSE: RHE) shares jumped 18.04 percent to close at $0.3010 on Tuesday.
    Precipio, Inc. (NASDAQ: PRPO) shares gained 16.61 percent to close at $0.49 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    Arcturus Therapeutics Ltd. (NASDAQ: ARCT) rose 16.09 percent to close at $7.00 on Tuesday.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 14.53 percent to close at $62.65 after reporting upbeat Q4 results.
    NanoString Technologies, Inc. (NASDAQ: NSTG) shares surged 12.64 percent to close at $13.19.
    Geron Corporation (NASDAQ: GERN) gained 12.12 percent to close at $4.07 on Tuesday.
    Quotient Limited (NASDAQ: QTNT) shares climbed 11.58 percent to close at $6.55 on Tuesday.
    American Equity Investment Life Holding Company (NYSE: AEL) rose 11.23 percent to close at $32.28 following a report from Reuters that the company is looking for a sale.
    iQIYI, Inc. (NASDAQ: IQ) gained 11.15 percent to close at $22.52.
    Veracyte, Inc. (NASDAQ: VCYT) rose 10.4 percent to close at $7.11.
    Stein Mart, Inc. (NASDAQ: SMRT) gained 10.26 percent to close at $3.33. Stein Mart is expected to release quarterly earnings on May 23.
    MiMedx Group, Inc. (NASDAQ: MDXG) shares rose 10.11 percent to close at $8.06.
    The Container Store Group, Inc. (NYSE: TCS) gained 8.2 percent to close at $8.18. Container Store reported weaker-than-expected earnings for its fourth quarter after the closing bell.
    Photronics, Inc. (NASDAQ: PLAB) shares gained 7.69 percent to close at $9.10 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.4 percent to close at $59.03 after reporting a $10 billion buyback plan.

     

  • [By Ethan Ryder]

    ValuEngine lowered shares of Forward Pharma A/S (NASDAQ:FWP) from a hold rating to a sell rating in a report published on Thursday morning.

    NASDAQ:FWP opened at $2.49 on Thursday. Forward Pharma A/S has a fifty-two week low of $1.63 and a fifty-two week high of $7.93.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Forward Pharma A/S (NASDAQ: FWP) fell 15.2 percent to $3.51 in pre-market trading after surging 88.18 percent on Tuesday.
    Pfenex Inc. (NASDAQ: PFNX) shares fell 15 percent to $5.85 in pre-market trading after the company announced an offering of common stock.
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) fell 17.6 percent to $47.75 in pre-market trading after the company reported downbeat results for its first quarter and issued a weak earnings forecast for the second quarter.
    Container Store Group, Inc. (NYSE: TCS) fell 13 percent to $7.15 in pre-market trading after reporting weaker-than-expected earnings for its fourth quarter.
    Ardelyx, Inc. (NASDAQ: ARDX) shares fell 12.1 percent to $4.00 in pre-market trading after reporting pricing of public offering of common stock.
    Boston Scientific Corporation (NYSE: BSX) shares fell 9.8 percent to $27.31 in pre-market trading.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 6.5 percent to $6.60 in pre-market trading.
    Target Corporation (NYSE: TGT) shares fell 5.8 percent to $71.02 in pre-market trading. Target reported weaker-than-expected earnings for its first quarter, while sales exceeded estimates.
    PBF Energy Inc. (NYSE: PBF) shares fell 5.7 percent to $42.42 in pre-market trading

Leave a Reply

Your email address will not be published. Required fields are marked *